Found: 5
Select item for more details and to access through your institution.
Characteristics and Related Factors of One-year Transition in Exercise Tolerance Following an Emergency Declaration due to the Coronavirus Disease 2019 Pandemic in Patients on Phase III Cardiac Rehabilitation.
- Published in:
- Physical Therapy Research, 2023, v. 26, n. 2, p. 50, doi. 10.1298/ptr.E10232
- By:
- Publication type:
- Article
Does Treatment of Impaired Glucose Tolerance Improve Cardiovascular Outcomes in Patients with Previous Myocardial Infarction?
- Published in:
- Cardiovascular Drugs & Therapy, 2017, v. 31, n. 4, p. 401, doi. 10.1007/s10557-017-6740-3
- By:
- Publication type:
- Article
Effect of Luseogliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, and Dipeptidyl-Peptidase 4 Inhibitors on the Quality-of-Life and Treatment Satisfaction of Patients With Type 2 Diabetes Mellitus: A Subanalysis of a Multicenter, Open-Label, Randomized-Controlled Trial (J-SELECT Study)
- Published in:
- Diabetes Therapy, 2024, v. 15, n. 6, p. 1403, doi. 10.1007/s13300-024-01575-w
- By:
- Publication type:
- Article
Overall Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitor Luseogliflozin Versus Dipeptidyl-Peptidase 4 Inhibitors: Multicenter, Open-Label, Randomized-Controlled Trial (J-SELECT study).
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 9, p. 1517, doi. 10.1007/s13300-023-01438-w
- By:
- Publication type:
- Article
Impact of the COVID‐19 pandemic on exercise tolerance and patient outcomes with Phase III cardiac rehabilitation in Japan: A multicenter study.
- Published in:
- Clinical Physiology & Functional Imaging, 2023, v. 43, n. 5, p. 318, doi. 10.1111/cpf.12823
- By:
- Publication type:
- Article